Liquidia Technologies, Inc. (NASDAQ:LQDA) Receives Consensus Recommendation of "Buy" from Brokerages

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) has earned an average rating of "Buy" from the nine brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $26.89.

Several research firms have recently issued reports on LQDA. Bank of America dropped their price target on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Raymond James Financial raised their price target on shares of Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a research note on Friday, May 9th. HC Wainwright raised their price target on shares of Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a research note on Wednesday, May 28th. Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Finally, Scotiabank raised their price target on shares of Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research note on Wednesday, May 28th.

Liquidia Technologies Price Performance

NASDAQ:LQDA traded up $0.19 on Friday, hitting $12.25. The company had a trading volume of 1,028,159 shares, compared to its average volume of 1,258,024. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of -7.75 and a beta of -0.01. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. The firm has a 50 day moving average of $15.07 and a two-hundred day moving average of $14.32. Liquidia Technologies has a 52 week low of $8.26 and a 52 week high of $19.41.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The company had revenue of $3.12 million during the quarter, compared to the consensus estimate of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. On average, research analysts anticipate that Liquidia Technologies will post -1.51 earnings per share for the current year.

Insider Activity at Liquidia Technologies

In other news, insider Rajeev Saggar sold 2,450 shares of the stock in a transaction on Monday, April 21st. The shares were sold at an average price of $13.67, for a total transaction of $33,491.50. Following the completion of the sale, the insider directly owned 263,152 shares in the company, valued at $3,597,287.84. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Michael Kaseta sold 8,283 shares of the stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $112,400.31. Following the sale, the chief financial officer owned 396,315 shares of the company's stock, valued at approximately $5,377,994.55. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,138 shares of company stock valued at $450,233 over the last 90 days. 26.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Liquidia Technologies

Large investors have recently modified their holdings of the company. Rhumbline Advisers grew its holdings in Liquidia Technologies by 3.5% in the fourth quarter. Rhumbline Advisers now owns 80,652 shares of the company's stock worth $948,000 after purchasing an additional 2,741 shares during the period. Bank of New York Mellon Corp grew its holdings in Liquidia Technologies by 3.3% in the fourth quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company's stock worth $2,218,000 after purchasing an additional 6,034 shares during the period. Steward Partners Investment Advisory LLC acquired a new stake in Liquidia Technologies in the fourth quarter worth $59,000. Charles Schwab Investment Management Inc. grew its holdings in Liquidia Technologies by 9.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 428,570 shares of the company's stock worth $5,040,000 after purchasing an additional 38,313 shares during the period. Finally, Arizona State Retirement System grew its holdings in Liquidia Technologies by 20.3% in the fourth quarter. Arizona State Retirement System now owns 15,888 shares of the company's stock worth $187,000 after purchasing an additional 2,685 shares during the period. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).